About us

SCIENION is a global market leader in ultra-low volume precision dispensing and microarray as well as biosensor technologies.

Our customers in the entire life science sector benefit from an integrated product portfolio and services advancing cost-efficient multiplex analysis, miniaturization and automation – from early research to high throughput production.

Mission

SCIENION wants to improve and accelerate the development of innovative, reliable, cost-efficient diagnostic and bioanalysis test platforms for the sake of patients, consumers, public health and environmental protection all over the world. We support our customers in any way to achieve this goal and we strive to be the number one partner for all players with the same objective.

Inspired by the needs of our customers

Based on our proprietary platform technologies, sciDROP PICO and cellenONE, our longstanding expertise and continuous inspiration by our customers’ needs, SCIENION provides a unique product portfolio comprising hardware, consumables and services.

Products & Services

Our worldwide customers in academia and industry – from small and medium-sized enterprises to large international corporations – rely on our products and services for almost any application in human and veterinary diagnostics as well as in bioanalysis in the food and environmental sector.

Quality management has always been key for us. SCIENION is certified according to ISO 9001:2015.

Strongly committed to R&D

SCIENION is strongly committed to R&D – with the aim to shape and accelerate the development of next generation diagnostic and bioanalysis test platforms. Beside internal research efforts, we take part in various national and international research projects to develop innovative products – together with academic and industrial partners.

Part of the BICO Group

Founded in 2016, BICO (formerly CELLINK) is the world’s leading bioconvergence company, organized into three business areas: BiosciencesBioautomation, and Bioprinting. Our products aim to reduce the organ shortage and speed up drug development by providing accessible life science solutions that combine biology and technology, fundamentally shifting the global healthcare industry.

Using a combination of robotics, artificial intelligence, advanced genomics, and 3D bioprinting, our innovative technologies enable researchers and practitioners in the life sciences to conduct cell line development, perform high-throughput drug screening and diagnostics, and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. BICO is the future of life-saving treatments, as we enable our customers to improve people’s health and lives.

We have over 32,000 installed instruments in more than 3,500 laboratories, including the top 20 pharmaceutical companies. They are being used in more than 65 countries, and have been cited in more than 11,000 publications. BICO is listed on Nasdaq Stockholm under BICO.

csm_mpimg_logo_acbfbf0659

Founded in 2000 in Berlin as a spin-off of the Max-Planck-Institute for Molecular Genetics, SCIENION today operates from Dortmund and Berlin, and has subsidiaries in Tempe, Arizona and Princeton, New Jersey, USA. Assay development and large scale manufacturing are provided from North America and Europe. Our global presence is supported by an efficient network of distributors.

Logo-berlin

SCIENION’s proprietary microarray and ultra-low volume liquid handling technologies were awarded twice with the “Innovationspreis Berlin-Brandenburg”.

The annual prize is jointly awarded by the German Federal States of Berlin and Brandenburg for product and process innovations and innovative technology services.

Our sciFLEXARRAYER dispenser was also awarded with the Product Technology Innovation Award by Materials Science Society AVS.

SCIENION’s Lyon-based subsidiary Cellenion in France, founded in 2016, focuses on controlled single cell dispensing technologies. Together with Biopredic International, Cellenion operates the joint “CellSpace” laboratory for regenerative liver sciences at Hospital Paul-BrousseI near Paris.

We are members of the following organizations